How vegan, vegetarian, or omnivorous diets relate to blood levels of brain proteins NfL and GFAP
Official title: Vegan, Vegeratian, or Omnivore: Dietary Effects on the Brain Tissue Biomarkers
Run by Salzburger Landeskliniken · NCT07312994 · Data updated 2026-11-12
This study will test whether following a vegan, vegetarian, or omnivorous diet changes blood levels of the brain proteins NfL and GFAP in healthy adults aged 18–40.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 40 Years |
| Sex | All |
| Enrollment | 300 (estimated) |
| Sponsor | Salzburger Landeskliniken Academic / other |
| Locations | 1 site (Salzburg, State of Salzburg) |
| Status | Recruiting |
| Started | December 18, 2025 |
| Main results expected | April 2026 |
| Study ends | September 2026 |
| Registry record updated | December 31, 2025 |
| Trial ID | NCT07312994 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal participants are healthy, nonpregnant adults aged 18–40 who have consistently followed a vegan, vegetarian, or omnivorous diet for at least one consecutive year and can provide informed consent.
✕Probably not a fit
People with diagnosed neurological disorders, recent moderate to severe infections, recent trauma or surgery, active eating disorders, excessive alcohol use, pregnancy, significant recent BMI swings, or long-term PPI use are unlikely to benefit or be eligible for this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is an observational, likely cross-sectional study enrolling healthy adults aged 18–40 who have followed a vegan, vegetarian, or omnivorous diet for at least one year. Participants provide consent and undergo blood draws to measure neurofilament light chain (NfL) and glial fibrillary acidic protein (GFAP) concentrations. Laboratory immunoassays will quantify biomarker levels and statistical analyses will compare levels across diet groups while controlling for key confounders such as BMI, recent infection, and medication use. Exclusion criteria remove individuals with neurological disease, recent significant illness or surgery, pregnancy, eating disorders, excessive alcohol use, or prolonged PPI use to reduce bias from non-dietary factors.
Why it matters
Potential benefit: If the findings show diet-related differences in NfL or GFAP, this could clarify whether common dietary patterns influence blood markers of brain health and guide future dietary or mechanistic research.
How similar studies have gone: Some prior research has linked diet patterns to brain health measures like cognition or imaging, but using blood NfL and GFAP in healthy young adults is relatively novel and not yet well established.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Healthy individuals who have followed a vegan, vegetarian, or omnivorous diet for at least one consecutive year * Aged between 18 and 40 years * Provision of written informed consent Exclusion Criteria: * Diagnose neurological disorders (e.g. neurodegenerative, inflammatory, autoimmune, infectious, vascular) * Eating disorders * Excessive alcohol consumption * Pregnancy * Recent moderate to severe infection (within the past 12 weeks) , including SARS-CoV-2 * Recent trauma, injury, or surgery (within the past 12 weeks) * Significant BMI fluctuations (\>5 points) within the last year * Patients who have been using Proton pump inhibitors (PPIs) for an extended period (e.g., 1 month).
Where it's running
-
Christian-Doppler-Klinik
Salzburg, State of Salzburg, Austria Recruiting
Study contacts
- Study coordinator: Tobias Moser, Prof.
- Email: t.moser@salk.at
- Phone: +435725534720
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
How a vegetarian diet affects digestion of pea protein in young and older adults
We will test whether pea protein is broken down and used differently by young and older adults who follow vegetarian or omnivorous diets.
-
Diet to reduce pain from diabetic peripheral neuropathy
This compares a whole-food, plant-based, no-added-oil diet with usual medications to see if it lowers pain and improves nerve symptoms in adults with painful diabetic neuropathy.
-
Medium-term outcomes of treatments for antibody-associated autoimmune encephalitis
This project will try three common initial treatment approaches — first-line therapy alone, first-line plus rituximab, or first-line with dual immunosuppression — in adults and children with antibody-associated autoimmune encephalitis to see which leads to better medium-term recovery.
-
Using brain stimulation and digital training to improve cognitive function in older adults
This study is testing whether a combination of brain stimulation and digital training can help improve thinking skills in older adults with Mild Cognitive Impairment and Alzheimer's Disease.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.